Impact of aging on immune function in the pathogenesis of pulmonary diseases: potential for therapeutic targets

References

• Hernandez-Gonzalez F. Chapter 3 - Lung aging and senescence in health and disease, in cellular senescence in disease. M. Serrano and D. Muñoz-Espín, et al., Editors. Academic Press; 2022. p. 61–80.
   Google Scholar
• Schneider JL, Rowe JH, Garcia-de-Alba C, et al. The aging lung: physiology, disease, and immunity. Cell. 2021;184(8):1990–2019. DOI:10.1016/j.cell.2021.03.005
   PubMed Web of Science ®Google Scholar
• López-Otín C, Blasco MA, Partridge L, et al. The hallmarks of aging. Cell. 2013;153(6):1194–1217. DOI:10.1016/j.cell.2013.05.039
   PubMed Web of Science ®Google Scholar
• Budinger GRS, Kohanski RA, Gan W, et al. The intersection of aging biology and the pathobiology of lung diseases: a Joint NHLBI/NIA WOrkshop. J Gerontol A Biol Sci Med Sci. 2017;72(11):1492–1500. DOI:10.1093/gerona/glx090
   PubMed Web of Science ®Google Scholar
• Brandenberger C, Mühlfeld C. Mechanisms of lung aging. Cell Tissue Res. 2017;367(3):469–480.
   PubMed Web of Science ®Google Scholar
• Weyand CM, Goronzy JJ. Aging of the immune system. mechanisms and therapeutic targets. Ann Am Thorac Soc. 2016;13(Suppl 5):S422–s428.
   PubMedGoogle Scholar
• Kolb JP, Oguin TH, Oberst A, et al. Programmed cell death and inflammation: winter is coming. Trends Immunol. 2017;38(10):705–718. DOI:10.1016/j.it.2017.06.009
   PubMed Web of Science ®Google Scholar
• Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the immune system. Transplant Int. 2009;22(11):1041–1050.
   PubMed Web of Science ®Google Scholar
• Lowery EM, Lowery E, Kuhlmann E, et al. The aging lung. Clin Interv Aging. 2013;8:1489–1496.
   PubMed Web of Science ®Google Scholar
• Gouin JP, Hantsoo L, Kiecolt-Glaser JK. Immune dysregulation and chronic stress among older adults: a review. Neuroimmunomodulation. 2008;15(4–6):251–259.
   PubMed Web of Science ®Google Scholar
• Halawa S, Pullamsetti SS, Bangham CRM, et al. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective. Nat Rev Cardiol. 2022;19(5):314–331. DOI:10.1038/s41569-021-00640-2
   PubMed Web of Science ®Google Scholar
• Hajishengallis G. Too old to fight? Aging and its toll on innate immunity. Mol Oral Microbiol. 2010;25(1):25–37.
   PubMed Web of Science ®Google Scholar
• Meyer KC. The role of immunity in susceptibility to respiratory infection in the aging lung. Respir Physiol. 2001;128(1):23–31.
   PubMedGoogle Scholar
• Iwasaki A, Foxman EF, Molony RD. Early local immune defences in the respiratory tract. Nat Rev Immunol. 2017;17(1):7–20.
   PubMed Web of Science ®Google Scholar
• Lloyd CM, Marsland BJ. Lung Homeostasis: influence of age, microbes, and the immune system. Immunity. 2017;46(4):549–561.
   PubMed Web of Science ®Google Scholar
• Gibbings SL, Thomas SM, Atif SM, et al. Three unique interstitial macrophages in the murine lung at steady State. Am J Respir Cell Mol Biol. 2017;57(1):66–76. DOI:10.1165/rcmb.2016-0361OC
   PubMed Web of Science ®Google Scholar
• Nikolich-Žugich J. The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol. 2018;19(1):10–19.
   PubMed Web of Science ®Google Scholar
• Boe DM, Boule LA, Kovacs EJ. Innate immune responses in the ageing lung. Clin Exp Immunol. 2017;187(1):16–25.
   PubMed Web of Science ®Google Scholar
• Radicioni G, Cao R, Carpenter J, et al. The innate immune properties of airway mucosal surfaces are regulated by dynamic interactions between mucins and interacting proteins: the mucin interactome. Mucosal Immunol. 2016;9(6):1442–1454. DOI:10.1038/mi.2016.27
   PubMed Web of Science ®Google Scholar
• Kumar V. Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis-associated acute lung injury. Front Immunol. 2020;11:1722.
   PubMed Web of Science ®Google Scholar
• Gollwitzer ES, Saglani S, Trompette A, et al. Lung microbiota promotes tolerance to allergens in neonates via PD-L1. Nat Med. 2014;20(6):642–647. DOI:10.1038/nm.3568
   PubMed Web of Science ®Google Scholar
• Wang J, Li F, Sun R, et al. Bacterial colonization dampens influenza-mediated acute lung injury via induction of M2 alveolar macrophages. Nat Commun. 2013;4:2106.
   PubMed Web of Science ®Google Scholar
• Montgomery RR, Shaw AC. Paradoxical changes in innate immunity in aging: recent progress and new directions. J Leukocyte Biol. 2015;98(6):937–943.
   PubMed Web of Science ®Google Scholar
• Quinn KM, Fox A, Harland KL, et al. Age-Related Decline in Primary CD8(+) T Cell Responses is Associated with the Development of Senescence in Virtual Memory CD8(+) T Cells. Cell Rep. 2018;23(12):3512–3524. DOI:10.1016/j.celrep.2018.05.057.
   PubMed Web of Science ®Google Scholar
• Hinojosa CA, Mgbemena V, Van Roekel S, et al. Enteric-delivered rapamycin enhances resistance of aged mice to pneumococcal pneumonia through reduced cellular senescence. Exp Gerontol. 2012;47(12):958–965. DOI:10.1016/j.exger.2012.08.013
   PubMed Web of Science ®Google Scholar
• Shivshankar P, Boyd AR, Le Saux CJ, et al. Cellular senescence increases expression of bacterial ligands in the lungs and is positively correlated with increased susceptibility to pneumococcal pneumonia. Aging Cell. 2011;10(5):798–806. doi:10.1111/j.1474-9726.2011.00720.x.
   PubMed Web of Science ®Google Scholar
• Henson SM, Lanna A, Riddell NE, et al. P38 signaling inhibits mTORC1-independent autophagy in senescent human CD8+ T cells. J Clin Invest. 2014;124(9):4004–4016. DOI:10.1172/JCI75051
   PubMed Web of Science ®Google Scholar
• Kerstjens HA, Rijcken B, Schouten JP, et al. Decline of FEV1 by age and smoking status: facts, figures, and fallacies. Thorax. 1997;52(9):820–827. DOI:10.1136/thx.52.9.820
   PubMed Web of Science ®Google Scholar
• Kirsten M, et al. The effect of age on lung epithelial barrier function. Eur Respir J. 2018;52(suppl 62):OA2124.
   Google Scholar
• Stout-Delgado HW, Vaughan SE, Shirali AC, et al. Impaired NLRP3 inflammasome function in elderly mice during influenza infection is rescued by treatment with nigericin. J Immunol. 2012;188(6):2815–2824. DOI:10.4049/jimmunol.1103051
   PubMed Web of Science ®Google Scholar
• Kovacs EJ, Palmer JL, Fortin CF, et al. Aging and innate immunity in the mouse: impact of intrinsic and extrinsic factors. Trends Immunol. 2009;30(7):319–324. DOI:10.1016/j.it.2009.03.012
   PubMed Web of Science ®Google Scholar
• Murciano C, Yáñez A, O’Connor JE, et al. Influence of aging on murine neutrophil and macrophage function against Candida albicans. FEMS Immunol Med Microbiol. 2008;53(2):214–221. DOI:10.1111/j.1574-695X.2008.00418.x
   PubMedGoogle Scholar
• Fortin CF, McDonald PP, Lesur O, et al. Aging and neutrophils: there is still much to do. Rejuvenation Res. 2008;11(5):873–882. DOI:10.1089/rej.2008.0750
   PubMed Web of Science ®Google Scholar
• Simell B, Vuorela A, Ekström N, et al. Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis. Vaccine. 2011;29(10):1929–1934. DOI:10.1016/j.vaccine.2010.12.121
   PubMed Web of Science ®Google Scholar
• Gomez CR, Boehmer ED, Kovacs EJ. The aging innate immune system. Curr Opin Immunol. 2005;17(5):457–462.
   PubMed Web of Science ®Google Scholar
• Bowdish DME. The aging lung: is lung health good health for older adults? Chest. 2019;155(2):391–400.
   PubMed Web of Science ®Google Scholar
• Chiu C, Openshaw PJ. Antiviral B cell and T cell immunity in the lungs. Nat Immunol. 2015;16(1):18–26.
   PubMed Web of Science ®Google Scholar
• Haynes L, Swain SL. Why aging T cells fail: implications for vaccination. Immunity. 2006;24(6):663–666.
   PubMed Web of Science ®Google Scholar
• Toapanta FR, Ross TM. Impaired immune responses in the lungs of aged mice following influenza infection. Respir Res. 2009;10(1):112.
   PubMedGoogle Scholar
• Lee N, Shin MS, Kang I. T-cell biology in aging, with a focus on lung disease. J Gerontol A Biol Sci Med Sci. 2012;67(3):254–263.
   PubMed Web of Science ®Google Scholar
• Diller ML, Kudchadkar RR, Delman KA, et al. Balancing inflammation: the link between Th17 and Regulatory T Cells. Mediators Inflamm. 2016;2016:6309219.
   PubMed Web of Science ®Google Scholar
• Huang C, Li F, Wang J, et al. Innate-like lymphocytes and innate lymphoid cells in asthma. Clin Rev Allergy Immunol. 2020;59(3):359–370. DOI:10.1007/s12016-019-08773-6
   PubMed Web of Science ®Google Scholar
• Vernot JP. Senescence-associated pro-inflammatory cytokines and tumor cell plasticity. Front Mol Biosci. 2020;7:63.
   PubMed Web of Science ®Google Scholar
• Jackaman C, Tomay F, Duong L, et al. Aging and cancer: the role of macrophages and neutrophils. Ageing Res Rev. 2017;36:105–116.
   PubMed Web of Science ®Google Scholar
• Wang ZN, Su R-N, Yang B-Y, et al. Potential role of cellular senescence in asthma. Front Cell Dev Biol. 2020;8:59.
   PubMed Web of Science ®Google Scholar
• Duong L, Radley HG, Lee B, et al. Macrophage function in the elderly and impact on injury repair and cancer. Immun Ageing. 2021;18(1):4. DOI:10.1186/s12979-021-00215-2
   PubMed Web of Science ®Google Scholar
• Parimon T, Hohmann MS, Yao C. Cellular senescence: pathogenic mechanisms in lung fibrosis. Int J Mol Sci. 2021;22(12):6214.
   PubMed Web of Science ®Google Scholar
• Cho MH, Hobbs BD, Silverman EK. Genetics of chronic obstructive pulmonary disease: understanding the pathobiology and heterogeneity of a complex disorder. Lancet Respir Med. 2022;10(5):485–496.
   PubMed Web of Science ®Google Scholar
• Sharma G, Hanania NA, Shim YM. The aging immune system and its relationship to the development of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009;6(7):573–580.
   PubMedGoogle Scholar
• Halper-Stromberg E, Yun JH, Parker MM, et al. Systemic markers of adaptive and innate immunity are associated with chronic obstructive pulmonary disease severity and spirometric disease progression. Am J Respir Cell Mol Biol. 2018;58(4):500–509. DOI:10.1165/rcmb.2017-0373OC
   PubMed Web of Science ®Google Scholar
• Silver JS, Kearley J, Copenhaver AM, et al. Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs. Nat Immunol. 2016;17(6):626–635. doi:10.1038/ni.3443.
   PubMed Web of Science ®Google Scholar
• Safiri S, Carson-Chahhoud K, Noori M, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. BMJ. 2022;378:e069679.
   PubMedGoogle Scholar
• MacNee W. Pathology, pathogenesis, and pathophysiology. BMJ. 2006;332(7551):1202.
   Web of Science ®Google Scholar
• Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977;1(6077):1645–1648.
   PubMed Web of Science ®Google Scholar
• MacNee W. Is chronic obstructive pulmonary disease an accelerated aging disease? Ann Am Thorac Soc. 2016;13(Suppl 5):S429–s437.
   PubMed Web of Science ®Google Scholar
• Ito K, Barnes PJ. COPD as a disease of accelerated lung aging. Chest. 2009;135(1):173–180.
   PubMed Web of Science ®Google Scholar
• Divo MJ, Celli BR, Poblador-Plou B, et al. Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: evidence from the EpiChron Cohort. PLoS ONE. 2018;13(2):e0193143. DOI:10.1371/journal.pone.0193143
   PubMed Web of Science ®Google Scholar
• Behrendt CE. Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. Chest. 2005;128(3):1239–1244.
   PubMed Web of Science ®Google Scholar
• Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–750. DOI:10.1016/S0140-6736(07)61377-4
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang C, Yao W, et al. COPD in Chinese nonsmokers. Eur Respir J. 2009;33(3):509–518. DOI:10.1183/09031936.00084408
   PubMed Web of Science ®Google Scholar
• Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008;359(22):2355–2365.
   PubMed Web of Science ®Google Scholar
• Mercado N, Ito K, Barnes PJ. Accelerated ageing of the lung in COPD: new concepts. Thorax. 2015;70(5):482–489.
   PubMed Web of Science ®Google Scholar
• Pawelec G. Hallmarks of human “immunosenescence”: adaptation or dysregulation? Immun Ageing. 2012;9(1):15.
   PubMedGoogle Scholar
• Macallan DC, Wallace DL, Zhang Y, et al. B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. Blood. 2005;105(9):3633–3640. DOI:10.1182/blood-2004-09-3740
   PubMed Web of Science ®Google Scholar
• Caramori G, Casolari P, Barczyk A, et al. COPD immunopathology. Semin Immunopathol. 2016;38(4):497–515. DOI:10.1007/s00281-016-0561-5
   PubMed Web of Science ®Google Scholar
• Fragkou PC, Moschopoulos CD, Reiter R, et al. Host immune responses and possible therapeutic targets for viral respiratory tract infections in susceptible populations: a narrative review. Clin Microbiol Infect. 2022;28(10):1328–1334. DOI:10.1016/j.cmi.2022.03.010
   PubMed Web of Science ®Google Scholar
• Birch J, Anderson RK, Correia-Melo C, et al. DNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2015;309(10):L1124–1137. DOI:10.1152/ajplung.00293.2015
   PubMed Web of Science ®Google Scholar
• Simone R, Zicca A, Saverino D. The frequency of regulatory CD3+CD8+CD28- CD25+ T lymphocytes in human peripheral blood increases with age. J Leukocyte Biol. 2008;84(6):1454–1461.
   PubMed Web of Science ®Google Scholar
• Caramori G, Adcock IM, Casolari P, et al. Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer. Thorax. 2011;66(6):521–527. DOI:10.1136/thx.2010.156448
   PubMed Web of Science ®Google Scholar
• Ahmad T, Sundar IK, Tormos AM, et al. Shelterin telomere protection protein 1 reduction causes telomere attrition and cellular senescence via sirtuin 1 deacetylase in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2017;56(1):38–49. DOI:10.1165/rcmb.2016-0198OC
   PubMed Web of Science ®Google Scholar
• Yao H, Chung S, Hwang J-W, et al. SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. J Clin Invest. 2012;122(6):2032–2045. DOI:10.1172/JCI60132
   PubMed Web of Science ®Google Scholar
• Rahman I, Kinnula VL, Gorbunova V, et al. SIRT1 as a therapeutic target in inflammaging of the pulmonary disease. Prev Med. 2012;54(Suppl):S20–8. doi:10.1016/j.ypmed.2011.11.014.
   PubMedGoogle Scholar
• Rashid K, Sundar IK, Gerloff J, et al. Lung cellular senescence is independent of aging in a mouse model of COPD/emphysema. Sci Rep. 2018;8(1):9023. DOI:10.1038/s41598-018-27209-3
   PubMedGoogle Scholar
• Sundar IK, Rashid K, Gerloff J, et al. Genetic ablation of histone deacetylase 2 leads to lung cellular senescence and lymphoid follicle formation in COPD/emphysema. Faseb J. 2018;32(9):4955–4971. DOI:10.1096/fj.201701518R
   PubMed Web of Science ®Google Scholar
• Fernandes JR, Pinto TNC, Arruda LB, et al. Age-associated phenotypic imbalance in TCD4 and TCD8 cell subsets: comparison between healthy aged, smokers, COPD patients and young adults. Immun Ageing. 2022;19(1):9. DOI:10.1186/s12979-022-00267-y
   PubMed Web of Science ®Google Scholar
• Hernández Cordero AI, Yang CX, Yang J, et al. Airway aging and methylation disruptions in HIV-associated chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2022;206(2):150–160. DOI:10.1164/rccm.202106-1440OC
   PubMed Web of Science ®Google Scholar
• Baker JR, Donnelly LE, Barnes PJ. Senotherapy: a New Horizon for COPD Therapy. Chest. 2020;158(2):562–570.
   PubMed Web of Science ®Google Scholar
• Houssaini A, Breau M, Kebe K, et al. mTOR pathway activation drives lung cell senescence and emphysema. JCI Insight. 2018;3(3). DOI:10.1172/jci.insight.93203.
   PubMed Web of Science ®Google Scholar
• Sehgal M, Jakhete SM, Manekar AG, et al. Specific epigenetic regulators serve as potential therapeutic targets in idiopathic pulmonary fibrosis. Heliyon. 2022;8(8):e09773. DOI:10.1016/j.heliyon.2022.e09773
   PubMed Web of Science ®Google Scholar
• Chung JH, Landeras L. Probable UIP: what is the evidence that compels this classification and how is it different from the indeterminate category? Semin Roentgenol. 2019;54(1):15–20.
   PubMed Web of Science ®Google Scholar
• Noble PW, Barkauskas CE, Jiang D. Pulmonary fibrosis: patterns and perpetrators. J Clin Invest. 2012;122(8):2756–2762.
   PubMed Web of Science ®Google Scholar
• Cho SJ, Stout-Delgado HW. Aging and Lung Disease. Annu Rev Physiol. 2020;82(1):433–459.
   PubMedGoogle Scholar
• Olson AL, Gifford AH, Inase N, et al. The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype. Eur Respir Rev. 2018;27(150).
   PubMed Web of Science ®Google Scholar
• TE K Jr, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2083–2092. DOI:10.1056/NEJMoa1402582
   PubMed Web of Science ®Google Scholar
• Lederer DJ, Martinez FJ, Longo DL. Idiopathic Pulmonary Fibrosis. N Engl J Med. 2018;378(19):1811–1823.
   PubMed Web of Science ®Google Scholar
• Childs BG, Durik M, Baker DJ, et al. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med. 2015;21(12):1424–1435. DOI:10.1038/nm.4000
   PubMed Web of Science ®Google Scholar
• Panda A, Qian F, Mohanty S, et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol. 2010;184(5):2518–2527. DOI:10.4049/jimmunol.0901022
   PubMed Web of Science ®Google Scholar
• O’Dwyer DN, Ashley SL, Gurczynski SJ, et al. Lung microbiota contribute to pulmonary inflammation and disease progression in pulmonary fibrosis. Am J Respir Crit Care Med. 2019;199(9):1127–1138. DOI:10.1164/rccm.201809-1650OC
   PubMed Web of Science ®Google Scholar
• Yanai H, Shteinberg A, Porat Z, et al. Cellular senescence-like features of lung fibroblasts derived from idiopathic pulmonary fibrosis patients. Aging (Albany NY). 2015;7(9):664–672. DOI:10.18632/aging.100807
   PubMedGoogle Scholar
• Yang KE, Kwon J, Rhim J-H, et al. Differential expression of extracellular matrix proteins in senescent and young human fibroblasts: a comparative proteomics and microarray study. Mol Cells. 2011;32(1):99–106. DOI:10.1007/s10059-011-0064-0
   PubMed Web of Science ®Google Scholar
• Angelidis I, Simon LM, Fernandez IE, et al. An atlas of the aging lung mapped by single cell transcriptomics and deep tissue proteomics. Nat Commun. 2019;10(1):963. doi:10.1038/s41467-019-08831-9.
   PubMedGoogle Scholar
• Liu Y, Li Z, Xiao H, et al. USP13 deficiency impairs autophagy and facilitates age-related lung fibrosis. Am J Respir Cell Mol Biol. 2023;68(1):49–61. DOI:10.1165/rcmb.2022-0002OC
   PubMed Web of Science ®Google Scholar
• Calhoun C, Shivshankar P, Saker M, et al. Senescent cells contribute to the physiological remodeling of aged lungs. J Gerontol A Biol Sci Med Sci. 2016;71(2):153–160. DOI:10.1093/gerona/glu241
   PubMed Web of Science ®Google Scholar
• Casaluce F, Sgambato A, Maione P, et al. Lung cancer, elderly and immune checkpoint inhibitors. J Thorac Dis. 2018;10(Suppl 13):S1474–1481. DOI:10.21037/jtd.2018.05.90
   PubMedGoogle Scholar
• Schabath MB, Cote ML. Cancer progress and priorities: lung cancer. Cancer Epidemiol Biomarkers Prev. 2019;28(10):1563–1579.
   PubMed Web of Science ®Google Scholar
• Weiss SA, Han J, Darvishian F, et al. Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts. J Transl Med. 2016;14(1):299. DOI:10.1186/s12967-016-1026-2
   PubMedGoogle Scholar
• van den Berge M, ten Hacken NHT, van der Wiel E, et al. Treatment of the bronchial tree from beginning to end: targeting small airway inflammation in asthma. Allergy. 2013;68(1):16–26. DOI:10.1111/all.12062
   PubMed Web of Science ®Google Scholar
• van den Berge M, ten Hacken NHT, Cohen J, et al. Small airway disease in asthma and COPD: clinical implications. Chest. 2011;139(2):412–423. DOI:10.1378/chest.10-1210
   PubMed Web of Science ®Google Scholar
• Mathur SK, Nyenhuis SM. Changes in immune function in asthma in the elderly. Aging Health. 2009;5(4):551–559.
   PubMedGoogle Scholar
• Holgate ST, Wenzel S, Postma DS, et al. Asthma. Nat Rev Dis Primers. 2015;1(1):15025. DOI:10.1038/nrdp.2015.25
   PubMed Web of Science ®Google Scholar
• Conde E, Bertrand R, Balbino B, et al. Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice. Nat Commun. 2021;12(1):2574. DOI:10.1038/s41467-021-22834-5
   PubMed Web of Science ®Google Scholar
• Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol. 2015;16(1):45–56.
   PubMed Web of Science ®Google Scholar
• Liu X, Netto KG, Sokulsky LA, et al. Single-cell RNA transcriptomic analysis identifies Creb5 and CD11b-DCs as regulator of asthma exacerbations. Mucosal Immunol. 2022;15(6):1363–1374. DOI:10.1038/s41385-022-00556-1
   PubMed Web of Science ®Google Scholar
• Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005;201(6):937–947. DOI:10.1084/jem.20041901
   PubMed Web of Science ®Google Scholar
• Sansoni P, Vescovini R, Fagnoni F, et al. The immune system in extreme longevity. Exp Gerontol. 2008;43(2):61–65. DOI:10.1016/j.exger.2007.06.008
   PubMed Web of Science ®Google Scholar
• Sakata-Kaneko S, Wakatsuki Y, Matsunaga Y, et al. Altered Th1/Th2 commitment in human CD4+ T cells with ageing. Clin Exp Immunol. 2000;120(2):267–273. doi:10.1046/j.1365-2249.2000.01224.x.
   PubMed Web of Science ®Google Scholar
• Pritz T, Lair J, Ban M, et al. Plasma cell numbers decrease in bone marrow of old patients. Eur J Immunol. 2015;45(3):738–746. DOI:10.1002/eji.201444878
   PubMed Web of Science ®Google Scholar
• McKenna RW, Washington LT, Aquino DB, et al. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood. 2001;98(8):2498–2507. DOI:10.1182/blood.V98.8.2498
   PubMed Web of Science ®Google Scholar
• Dailey RW, Eun S-Y, Russell CE, et al. B cells of aged mice show decreased expansion in response to antigen, but are normal in effector function. Cell Immunol. 2001;214(2):99–109. DOI:10.1006/cimm.2001.1894
   PubMed Web of Science ®Google Scholar
• Ventura MT, Scichilone N, Paganelli R, et al. Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms. Clin Mol Allergy. 2017;15(1):2. DOI:10.1186/s12948-017-0059-2
   PubMedGoogle Scholar
• Dunn RM, Busse PJ, Wechsler ME. Asthma in the elderly and late-onset adult asthma. Allergy. 2018;73(2):284–294.
   PubMed Web of Science ®Google Scholar
• Crisford H, Sapey E, Rogers GB, et al. Neutrophils in asthma: the good, the bad and the bacteria. Thorax. 2021;76(8):835–844. DOI:10.1136/thoraxjnl-2020-215986
   PubMed Web of Science ®Google Scholar
• Bullone Mand Lavoie JP, Lavoie J-P. The contribution of oxidative stress and inflamm-aging in human and equine asthma. Int J Mol Sci. 2017;18(12):2612.
   PubMed Web of Science ®Google Scholar
• Godwin MS, Reeder KM, Garth JM, et al. IL-1RA regulates immunopathogenesis during fungal-associated allergic airway inflammation. JCI Insight. 2019;4(21).
   PubMed Web of Science ®Google Scholar
• Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol. 2001;108(2):184–190. DOI:10.1067/mai.2001.117880
   PubMed Web of Science ®Google Scholar
• Pavord ID, Korn S, Howarth P, et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012;380(9842):651–659. DOI:10.1016/S0140-6736(12)60988-X
   PubMed Web of Science ®Google Scholar
• Hua F, Ribbing J, Reinisch W, et al. A pharmacokinetic comparison of anrukinzumab, an anti- IL-13 monoclonal antibody, among healthy volunteers, asthma and ulcerative colitis patients. Br J Clin Pharmacol. 2015;80(1):101–109. DOI:10.1111/bcp.12589
   PubMed Web of Science ®Google Scholar
• Soma T, Uchida Y, Hoshino Y, et al. Relationship between airway inflammation and airflow limitation in elderly asthmatics. Asia Pac Allergy. 2020;10(2):e17. DOI:10.5415/apallergy.2020.10.e17
   PubMed Web of Science ®Google Scholar
• Soma T, Nagata M. Immunosenescence, Inflammaging, and lung senescence in asthma in the elderly. Biomolecules. 2022;12(10):1456.
   PubMed Web of Science ®Google Scholar
• Busse PJ, Zhang TF, Srivastava K, et al. Effect of ageing on pulmonary inflammation, airway hyperresponsiveness and T and B cell responses in antigen-sensitized and -challenged mice. Clin Exp Allergy. 2007;37(9):1392–1403. DOI:10.1111/j.1365-2222.2007.02775.x
   PubMed Web of Science ®Google Scholar
• Kinyanjui MW, Shan J, Nakada EM, et al. Dose-Dependent Effects of IL-17 on IL-13–Induced Airway Inflammatory Responses and Airway Hyperresponsiveness. J Immunol. 2013;190(8):3859–3868. DOI:10.4049/jimmunol.1200506
   PubMed Web of Science ®Google Scholar
• Amor C, Feucht J, Leibold J, et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nature. 2020;583(7814):127–132. doi:10.1038/s41586-020-2403-9.
   PubMed Web of Science ®Google Scholar